These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8339811)

  • 1. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.
    Johnston ID; Gomm SA; Kalra S; Woodcock AA; Evans CC; Hind CR
    Eur Respir J; 1993 Jun; 6(6):891-3. PubMed ID: 8339811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
    Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
    Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic fibrosing alveolitis associated with peripheral neuropathy.
    Turton C; Jacobs JM
    Q J Med; 1983; 52(207):417-23. PubMed ID: 6316400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical importance of the dynamics of the cytological findings in lavage fluid in patients with biopsy-proven cryptogenic fibrosing alveolitis].
    Homolka J; Bohut V; Votava V; Voslárová Z; Zatloukal P
    Cas Lek Cesk; 1988 May; 127(19):589-92. PubMed ID: 3396044
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis.
    Turner-Warwick M; Haslam PL
    Am Rev Respir Dis; 1987 Jan; 135(1):26-34. PubMed ID: 3800151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of cryptogenic fibrosing alveolitis.
    Tukiainen P; Taskinen E; Holsti P; Korhola O; Valle M
    Thorax; 1983 May; 38(5):349-55. PubMed ID: 6879483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
    Johnston ID; Bleasdale C; Hind CR; Woodcock AA
    Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptogenic fibrosing alveolitis: diagnosis and treatment.
    Egan JJ; Hasleton PS
    Hosp Med; 1998 May; 59(5):364-8. PubMed ID: 9722386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic bronchoalveolar lavage in assessing the efficacy of the treatment of idiopathic fibrosing alveolitis].
    Gerasin VA; Zhuravlev AV; Novikova LN; Palamarchuk GF
    Ter Arkh; 1988; 60(12):63-6. PubMed ID: 3247657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging and therapy of cryptogenic fibrosing alveolitis.
    Turner-Warwick M
    Chest; 1986 Mar; 89(3 Suppl):148S-150S. PubMed ID: 3948577
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis.
    du Bois RM; Wells AU
    Eur Respir J Suppl; 2001 Sep; 32():43s-55s. PubMed ID: 11816824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.
    Rudd RM; Haslam PL; Turner-Warwick M
    Am Rev Respir Dis; 1981 Jul; 124(1):1-8. PubMed ID: 7258815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Peckham RM; Shorr AF; Helman DL
    Respiration; 2004; 71(2):165-9. PubMed ID: 15031572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
    Johnson MA; Kwan S; Snell NJ; Nunn AJ; Darbyshire JH; Turner-Warwick M
    Thorax; 1989 Apr; 44(4):280-8. PubMed ID: 2669218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.
    Agustí C; Xaubet A; Ballester E; Alarcón A; Picado C
    Thorax; 1993 Jan; 48(1):68-9. PubMed ID: 8434357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.
    Bourke SC; Clague H
    Postgrad Med J; 2000 Oct; 76(900):618-24. PubMed ID: 11009575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.